D-0502-2017 Class II Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-0502-2017 was initiated by Sun Pharmaceutical Industries, Inc. on Jan 5, 2017 and is designated Class II. Reason for recall: Presence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identified as a broken piece of wire rope from the manufacturing equipment. The recall status is terminated (terminated Jun 29, 2018). Affected quantity: 22,915 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 8, 2017
Initiation Date
Jan 5, 2017
Termination Date
Jun 29, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22,915 bottles

Product description

Alfuzosin Hydrochloride Extended-release Tablets, 10 mg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, Gujarat, India, NDC 47335-956-88.

Reason for recall

Presence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identified as a broken piece of wire rope from the manufacturing equipment.

Distribution pattern

Nationwide in the USA and Puerto Rico.

Code information

Lot #: JKR5219A, JKR5200A, JKR5220A, JKR5221A, JKR5222A, Exp 03/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0502-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0502-2017. Report a data issue: hello@regdatalab.com.